Go back to all lawsuits

Sanofi-Aventis US LLC et al. v. Merck Sharp & Dohme Corp. (Claim Construction)

Defendant: Merck Sharp & Dohme Corp.

Court: District of Delaware

Date: Jan 19, 2018

Docket: 1-16-cv-00812

Judge: Judge Richard G. Andrews

The Court in Sanofi-Aventis US LLC et al. v. Merck Sharp & Dohme Corp. construed terms of the following U.S. Patents.  The Court’s constructions can be found in the attached order.

  1. 1 term of U.S. Patent No. 7,476,652 (entitled “Acidic insulin preparations having improved stability”)
  2. 1 term of U.S. Patent No. 7,713,930 (entitled “Acidic insulin preparations having improved stability”)
  3. 4 terms of U.S. Patent No. 8,603,044 (entitled “Pen-type injector”)
  4. 4 terms of U.S. Patent No. 8,679,069 (entitled “Pen-type injector”)
  5. 4 terms of U.S. Patent No. 8,992,486 (entitled “Pen-type injector”)
  6. 4 terms of U.S. Patent No. 9,457,152 (entitled “Drive mechanism for a medication delivery device and medication delivery device”)
  7. 4 terms of U.S. Patent No. 9,526,844 (entitled “Pen-type injector”)
  8. 5 terms of U.S. Patent No. 9,533,105 (entitled “Drive mechanisms suitable for use in drug delivery devices”)
  9. 4 terms of U.S. Patent No. 9,592,348 (entitled “Assembly for a drug delivery device and drug delivery device”)
  10. 5 terms of U.S. Patent No. 9,604,008 (entitled “Drive mechanisms suitable for use in drug delivery devices”)

Go back to all lawsuits